Stock Analysis on Net
Stock Analysis on Net

Edwards Lifesciences Corp. (NYSE:EW)

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Beginner level

The balance sheet provides creditors, investors, and analysts with information on company’s resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company’s assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Edwards Lifesciences Corp., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

Microsoft Excel LibreOffice Calc
Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Accounts payable and accrued liabilities 822,100  849,400  722,000  876,900  751,700  673,200  623,900  876,600  661,200  584,000  674,100  753,200  693,700  562,500  584,800  532,500  532,800  478,200  458,300  476,200  532,500  445,200  405,300 
Operating lease liabilities, current portion 24,200  23,800  24,900  25,500  24,100  23,800  22,600  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Short-term debt —  —  —  —  —  —  —  —  599,900  599,200  598,600  598,000  —  —  —  —  —  —  —  —  —  —  — 
Contingent consideration liabilities —  —  —  —  —  —  —  —  —  —  41,800  51,700  41,500  —  —  —  —  —  —  —  —  —  — 
Current liabilities 846,300  873,200  746,900  902,400  775,800  697,000  646,500  876,600  1,261,100  1,183,200  1,314,500  1,402,900  735,200  562,500  584,800  532,500  532,800  478,200  458,300  476,200  532,500  445,200  405,300 
Long-term debt 594,900  594,700  594,600  594,400  594,200  594,100  593,900  593,800  593,600  593,900  456,000  438,400  1,034,000  1,016,800  847,900  822,300  600,600  602,500  602,200  599,900  604,900  600,300  602,700 
Contingent consideration liabilities 180,900  189,900  170,300  172,500  191,000  193,300  185,300  178,600  192,600  199,000  196,300  192,600  140,500  198,700  195,600  31,600  —  —  —  —  —  —  — 
Taxes payable 214,200  214,200  239,300  236,600  236,500  236,700  259,400  259,400  264,500  263,300  290,800  394,000  —  —  —  —  —  —  —  —  —  —  — 
Operating lease liabilities, long-term portion 71,000  66,000  55,700  58,900  52,400  50,400  49,700  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Uncertain tax positions 199,200  181,300  175,900  171,700  141,700  139,500  130,300  124,900  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Other liabilities 484,000  465,700  192,300  203,300  159,900  162,200  156,700  150,000  285,100  282,500  321,800  311,700  416,200  420,900  409,400  504,600  513,800  499,500  494,000  480,100  317,800  274,200  266,500 
Long-term liabilities 1,744,200  1,711,800  1,428,100  1,437,400  1,375,700  1,376,200  1,375,300  1,306,700  1,335,800  1,338,700  1,264,900  1,336,700  1,590,700  1,636,400  1,452,900  1,358,500  1,114,400  1,102,000  1,096,200  1,080,000  922,700  874,500  869,200 
Total liabilities 2,590,500  2,585,000  2,175,000  2,339,800  2,151,500  2,073,200  2,021,800  2,183,300  2,596,900  2,521,900  2,579,400  2,739,600  2,325,900  2,198,900  2,037,700  1,891,000  1,647,200  1,580,200  1,554,500  1,556,200  1,455,200  1,319,700  1,274,500 
Preferred stock, $.01 par value, no shares outstanding —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Common stock, $1.00 par value 635,000  633,500  218,500  218,100  217,500  216,900  216,000  215,200  214,800  214,000  213,000  212,000  211,600  244,700  243,200  242,600  242,000  241,000  239,800  239,100  130,200  129,900  129,400 
Additional paid-in capital 1,381,600  1,323,900  1,675,900  1,623,300  1,570,400  1,512,300  1,449,400  1,384,400  1,341,200  1,209,500  1,229,100  1,166,900  1,129,500  1,267,000  1,207,600  1,167,800  1,091,100  1,020,200  933,400  946,800  1,001,300  964,100  925,000 
Retained earnings 4,255,500  3,930,300  4,052,200  3,741,600  3,461,400  3,186,700  2,944,400  2,694,700  2,687,700  2,461,800  2,179,100  1,962,100  1,964,900  4,331,900  4,145,800  3,906,300  3,747,800  3,606,400  3,479,800  3,336,800  3,196,100  3,078,000  2,965,300 
Accumulated other comprehensive loss (157,900) (146,100) (152,000) (156,000) (155,800) (138,200) (141,200) (138,500) (139,000) (150,800) (121,300) (132,700) (142,700) (157,800) (181,500) (198,400) (171,200) (178,700) (172,600) (182,600) (169,200) (146,600) (147,900)
Treasury stock, at cost (1,903,900) (1,902,500) (1,893,500) (1,278,700) (1,278,700) (1,277,400) (1,021,100) (1,015,400) (743,400) (570,300) (254,200) (252,100) (800) (2,746,200) (2,672,400) (2,499,300) (2,217,900) (2,217,700) (2,181,100) (1,837,000) (1,737,000) (1,736,800) (1,657,900)
Stockholders’ equity 4,210,300  3,839,100  3,901,100  4,148,300  3,814,800  3,500,300  3,447,500  3,140,400  3,361,300  3,164,200  3,245,700  2,956,200  3,162,500  2,939,600  2,742,700  2,619,000  2,691,800  2,471,200  2,299,300  2,503,100  2,421,400  2,288,600  2,213,900 
Total liabilities and stockholders’ equity 6,800,800  6,424,100  6,076,100  6,488,100  5,966,300  5,573,500  5,469,300  5,323,700  5,958,200  5,686,100  5,825,100  5,695,800  5,488,400  5,138,500  4,780,400  4,510,000  4,339,000  4,051,400  3,853,800  4,059,300  3,876,600  3,608,300  3,488,400 

Based on: 10-Q (filing date: 2020-10-26), 10-Q (filing date: 2020-07-27), 10-Q (filing date: 2020-04-28), 10-K (filing date: 2020-02-14), 10-Q (filing date: 2019-10-25), 10-Q (filing date: 2019-07-26), 10-Q (filing date: 2019-04-26), 10-K (filing date: 2019-02-15), 10-Q (filing date: 2018-10-26), 10-Q (filing date: 2018-07-27), 10-Q (filing date: 2018-04-27), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-10-27), 10-Q (filing date: 2017-07-28), 10-Q (filing date: 2017-04-28), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-10-28), 10-Q (filing date: 2016-07-29), 10-Q (filing date: 2016-04-29), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-10-29), 10-Q (filing date: 2015-07-29), 10-Q (filing date: 2015-04-29).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Edwards Lifesciences Corp.’s current liabilities increased from Q1 2020 to Q2 2020 but then slightly decreased from Q2 2020 to Q3 2020.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Edwards Lifesciences Corp.’s long-term liabilities increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Edwards Lifesciences Corp.’s total liabilities increased from Q1 2020 to Q2 2020 and from Q2 2020 to Q3 2020.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Edwards Lifesciences Corp.’s stockholders’ equity decreased from Q1 2020 to Q2 2020 but then increased from Q2 2020 to Q3 2020 exceeding Q1 2020 level.